What R77 covers · when clinicians use it
ICD-10 code R77 identifies Other abnormalities of plasma proteins in the U.S. ICD-10-CM clinical and billing record set. It sits within the Symptoms, Signs & Abnormal Findings chapter (R00–R99), the section that groups related diagnoses so providers, payers, and public-health agencies report them consistently. Clinicians and medical coders apply R77 when an encounter's findings match the Other abnormalities of plasma proteins description, attaching it to the patient record so downstream insurance claims, payer audits, quality reporting, and epidemiological surveillance all reference the same standardized diagnosis. The ICD-10-CM is maintained by the Centers for Medicare & Medicaid Services and the CDC's National Center for Health Statistics, with an updated official code set released each U.S. fiscal year — always verify R77 against the current CMS/CDC release and your payer's documentation guidance before final use. This page summarizes documentation context for R77 and is a coding reference, not clinical, diagnostic, or billing advice.
R77 refers to Other abnormalities of plasma proteins, covering findings like high ESR, abnormal red blood cell shapes, elevated blood glucose, unusual enzyme levels, inconclusive HIV tests, plasma protein anomalies, and drug substances detected in blood tests.
Symptoms
- Elevated erythrocyte sedimentation rate – R70
- Red blood cell abnormalities – R71
- High fasting or random glucose levels – R73
- Abnormal enzyme patterns (e.g., liver, cardiac enzymes) – R74
- Unclear HIV test results – R75
- Unexpected immune markers in blood – R76
- Plasma protein abnormalities – R77
- Drug detection without known use – R78
- General chemical anomalies – R79
Diagnosis
Blood abnormalities are identified through CBCs (complete blood counts), ESR tests, blood glucose panels, enzyme assays (like ALT, AST), HIV screenings, immunoglobulin tests, and toxicology panels depending on the clinical suspicion.
ICD10 Code Usage
ICD10 code R77 supports initial documentation of unusual laboratory results when a final clinical diagnosis has not yet been established, crucial for further investigation and medical billing.
Related Codes
- R70 – Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity
- R71 – Abnormality of red blood cells
- R73 – Elevated blood glucose level
- R74 – Abnormal serum enzyme levels
- R75 – Inconclusive laboratory evidence of human immunodeficiency virus [HIV]
- R76 – Other abnormal immunological findings in serum
- R78 – Findings of drugs and other substances, not normally found in blood
- R79 – Other abnormal findings of blood chemistry
FAQs
Q1: What is ICD10 code R77?
A: It documents Other abnormalities of plasma proteins based on laboratory anomalies requiring further clinical correlation.
Q2: Can abnormal blood chemistry indicate disease?
A: Yes, they often suggest underlying conditions like diabetes, infections, immune disorders, or toxicity.
Q3: What is an inconclusive HIV test?
A: A test where preliminary HIV antibodies or antigens are detected but not confirmed.
Q4: How is ESR interpreted?
A: Elevated ESR can signal inflammation, infection, or autoimmune diseases but needs clinical correlation.
Q5: Are incidental drug findings serious?
A: They can be medically relevant if unexpected substances are detected, especially in cases of overdose or substance use disorders.
Conclusion
ICD10 code R77 facilitates the reporting of Other abnormalities of plasma proteins, ensuring appropriate follow-up, additional diagnostics, and a complete clinical record based on abnormal blood and serum findings.